Environmental and clinical epidemiology of Aspergillus terreus: Data from a prospective surveillance study

Journal of Hospital Infection

Volumn 78, Issue 3, 2011, Pages 226-230

  Ruping M J G T ^a   Gerlach, S ^a   Fischer, G ^b   Lass Florl C ^c   Hellmich, M ^d   Vehreschild, J J ^a   Cornely, O A ^a,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Baden Wurttemberg State Health Office   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Aspergillus terreus; Colonisation; Invasive fungal disease; Surveillance

Indexed keywords

AMPHOTERICIN B;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; COLONY FORMING UNIT; EPIDEMIOLOGY; FEMALE; FUNGAL COLONIZATION; FUNGAL CONTAMINATION; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GERMANY; HUMAN; HUMIDITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CARRIER STATE; CLUSTER ANALYSIS; DRUG RESISTANCE, FUNGAL; ENVIRONMENTAL MICROBIOLOGY; FEMALE; GENOTYPE; GERMANY; HEMATOLOGIC NEOPLASMS; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; NASAL MUCOSA; PROSPECTIVE STUDIES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEASONS;

EID: 79958760238     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.01.020     Document Type: Article

References (15)

1. Viscoli C., Castagnola E. Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management?. Clin Infect Dis 2010, 50:1598-1600.
2. Oren I., Haddad N., Finkelstein R., Rowe J.M. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001, 4:257-262.
3. Iwen P.C., Davis J.C., Reed E.C., Winfield B.A., Hinrichs S.H. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 1994, 5:303-306.
4. Lass-Florl C., Grif K., Kontoyiannis D.P. Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol 2007, 8:2686-2690.
5. Lass-Florl C., Griff K., Mayr A., et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005, 2:201-207.
6. Lass-Florl C., Alastruey-Izquierdo A., Cuenca-Estrella M., Perkhofer S., Rodriguez-Tudela J.L. In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2009, 2:794-795.
7. Iwen P.C., Rupp M.E., Langnas A.N., Reed E.C., Hinrichs S.H. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998, 5:1092-1097.
8. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 12:1813-1821.
9. Blum G., Perkhofer S., Grif K., et al. A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 2008, 12:1146-1151.
10. Baddley J.W., Pappas P.G., Smith A.C., Moser S.A. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 2003, 12:5525-5529.
11. Blum G., Perkhofer S., Haas H., et al. Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother 2008, 4:1553-1555.
12. Sutton D.A., Sanche S.E., Revankar S.G., Fothergill A.W., Rinaldi M.G. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999, 7:2343-2345.
13. Steinbach W.J., Benjamin D.K., Kontoyiannis D.P., et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004, 2:192-198.
14. Guinea J., Pelaez T., Alcala L., Bouza E. Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 2006, 4:349-356.
15. Panackal A.A., Li H., Kontoyiannis D.P., et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis 2010, 12:1588-1597.